| Secondary |
| Product Used For Unknown Indication |
21.1% |
| Rheumatoid Arthritis |
10.5% |
| Hypertension |
9.6% |
| Drug Use For Unknown Indication |
9.6% |
| Pain |
5.1% |
| Herpes Zoster |
4.0% |
| Pyrexia |
3.9% |
| Breast Cancer |
3.6% |
| Constipation |
3.5% |
| Insomnia |
3.5% |
| Prophylaxis |
3.4% |
| Gastritis |
3.2% |
| Nasopharyngitis |
3.0% |
| Back Pain |
2.9% |
| Upper Respiratory Tract Inflammation |
2.7% |
| Cancer Pain |
2.5% |
| Abdominal Pain |
2.1% |
| Diabetes Mellitus |
2.0% |
| Chronic Hepatitis C |
2.0% |
| Gastric Ulcer |
1.9% |
|
| Interstitial Lung Disease |
10.7% |
| Pyrexia |
9.6% |
| Renal Failure Acute |
7.6% |
| Stevens-johnson Syndrome |
7.0% |
| Vomiting |
7.0% |
| White Blood Cell Count Decreased |
5.9% |
| Renal Impairment |
5.0% |
| Hepatic Function Abnormal |
4.6% |
| Renal Disorder |
4.6% |
| Toxic Epidermal Necrolysis |
4.3% |
| Liver Disorder |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Platelet Count Decreased |
3.7% |
| Melaena |
3.5% |
| Sepsis |
3.5% |
| Tubulointerstitial Nephritis |
3.3% |
| Pneumonia |
3.1% |
| Gastric Ulcer Haemorrhage |
2.8% |
| Pancytopenia |
2.8% |
| Thrombocytopenia |
2.8% |
|
| Concomitant |
| Rheumatoid Arthritis |
19.9% |
| Prophylaxis |
14.0% |
| Hypertension |
7.4% |
| Product Used For Unknown Indication |
6.9% |
| Drug Use For Unknown Indication |
5.4% |
| Hepatitis C |
5.2% |
| Pain |
4.9% |
| Cancer Pain |
4.8% |
| Constipation |
4.7% |
| Chronic Hepatitis C |
4.5% |
| Insomnia |
4.1% |
| Gastritis |
3.3% |
| Osteoporosis |
3.0% |
| Diabetes Mellitus |
2.0% |
| Back Pain |
2.0% |
| Pyrexia |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Herpes Zoster |
1.6% |
| Multiple Myeloma |
1.5% |
| Breast Cancer |
1.4% |
|
| White Blood Cell Count Decreased |
11.2% |
| Interstitial Lung Disease |
9.4% |
| Vomiting |
8.4% |
| Pyrexia |
7.7% |
| Rash |
7.6% |
| Pneumonia |
6.7% |
| Renal Impairment |
6.3% |
| Platelet Count Decreased |
4.6% |
| Pneumocystis Jiroveci Pneumonia |
4.0% |
| Hepatic Function Abnormal |
3.7% |
| White Blood Cell Count Increased |
3.5% |
| Malaise |
3.5% |
| Sepsis |
3.4% |
| Nausea |
3.3% |
| Liver Disorder |
3.2% |
| Somnolence |
2.8% |
| Neutrophil Count Decreased |
2.7% |
| Stomatitis |
2.7% |
| Renal Failure Acute |
2.7% |
| Loss Of Consciousness |
2.6% |
|
| Interacting |
| Pharyngitis |
24.8% |
| Nasopharyngitis |
19.8% |
| Hepatitis C |
8.9% |
| Antipyresis |
5.9% |
| Gastritis Prophylaxis |
5.9% |
| Gastrointestinal Disorder |
4.0% |
| Upper Respiratory Tract Inflammation |
4.0% |
| Bronchitis |
3.0% |
| Hyperuricaemia |
3.0% |
| Oropharyngeal Pain |
3.0% |
| Pyrexia |
3.0% |
| Analgesia |
2.0% |
| Antibiotic Therapy |
2.0% |
| Hypertension |
2.0% |
| Postoperative Wound Infection |
2.0% |
| Product Used For Unknown Indication |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Analgesic Therapy |
1.0% |
| Antifungal Prophylaxis |
1.0% |
| Cervicobrachial Syndrome |
1.0% |
|
| Stevens-johnson Syndrome |
39.1% |
| Drug Interaction |
17.4% |
| Myoclonus |
13.0% |
| Sensory Disturbance |
8.7% |
| Gait Disturbance |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Renal Atrophy |
4.3% |
| Renal Disorder |
4.3% |
| Stomatitis |
4.3% |
|
